| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 30.75 | -0.46 (-1.47%) | 18.29 - 32.86 | 279.6 thousand (Below Avg) |
Market data as of 4:00PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 31.10 |
|---|---|
| Previous Close | 31.21 |
| Day's Range | 30.48 - 31.36 |
| Market Cap | 852.5M |
| Avg Volume (10 Day) | 459.6K |
| Price/Earnings (Trailing 12 Mo.) | 19.8x |
| Earnings Per Share (Trailing 12 Mo.) | 1.55 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Pass |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for BRLI
| BRLI | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 14.67% | |
| Net Income Growth (1yr) | 21.59% | |
| Total Debt/Equity | 0.10 | |
| LT Debt/Equity | 0.06 | |
| Earnings Yield | 5.05% | |
| Price/Sales | 1.27 |
| Company | Last | Change |
|---|---|---|
| Ironwood Pharmaceuticals Inc | 12.83 | +2.48% |
| Genomic Health Inc | 37.00 | 0.00% |
| Novadaq Technologies Inc | 13.53 | -0.29% |
| Nordion Inc | 7.80 | -2.74% |
| Trius Therapeutics Inc | 7.95 | +0.63% |
Data is delayed by at least 15 min.